Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asad Moten

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cell Research|May 7, 2014
Akt: a new activation mechanismYuan Gao, Asad Moten, Hui-Kuan Lin
Military Medicine|December 19, 2017
Global Health Engagement and The Department of Defense as a Vehicle for Security and Sustainable Global HealthAsad Moten, Daniel Schafer, Edwin K Burkett
Seminars in Cancer Biology|May 3, 2021
The foundational framework of tumors: Gametogenesis, p53, and cancerChunfang Liu, Asad Moten, Zhan Ma, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 20, 2011
Novel ARF/p53-independent senescence pathways in cancer repressionChia-Hsin Chan, Yuan Gao, Asad Moten, et al.
Colloids and Surfaces. B, Biointerfaces|March 25, 2014
The nano-plasma interface: Implications of the protein coronaJoy Wolfram, Yong Yang, Jianliang Shen, et al.
Seminars in Cancer Biology|February 5, 2020
The Skp2 Pathway: A Critical Target for Cancer TherapyZhen Cai, Asad Moten, Danni Peng, et al.
Military Medicine|January 27, 2021
A Paradigm Shift in Critical Care Infrastructure in Complex Settings: Evaluating an Ultraportable Operating Room to Improve Field Surgical SafetyDebbie L Teodorescu, Stephen Okajima, Asad Moten, et al.
Science Signaling|January 10, 2013
Cycles of ubiquitination and deubiquitination critically regulate growth factor-mediated activation of Akt signalingWei-Lei Yang, Guoxiang Jin, Chien-Feng Li, et al.
Cell|August 6, 2013
Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progressionChia-Hsin Chan, John Kenneth Morrow, Chien-Feng Li, et al.
Blood|September 21, 2011
The role of Skp2 in hematopoietic stem cell quiescence, pool size, and self-renewalJing Wang, Fei Han, Juan Wu, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cell Research|May 7, 2014
Akt: a new activation mechanismYuan Gao, Asad Moten, Hui-Kuan Lin
Military Medicine|December 19, 2017
Global Health Engagement and The Department of Defense as a Vehicle for Security and Sustainable Global HealthAsad Moten, Daniel Schafer, Edwin K Burkett
Seminars in Cancer Biology|May 3, 2021
The foundational framework of tumors: Gametogenesis, p53, and cancerChunfang Liu, Asad Moten, Zhan Ma, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 20, 2011
Novel ARF/p53-independent senescence pathways in cancer repressionChia-Hsin Chan, Yuan Gao, Asad Moten, et al.
Colloids and Surfaces. B, Biointerfaces|March 25, 2014
The nano-plasma interface: Implications of the protein coronaJoy Wolfram, Yong Yang, Jianliang Shen, et al.
Seminars in Cancer Biology|February 5, 2020
The Skp2 Pathway: A Critical Target for Cancer TherapyZhen Cai, Asad Moten, Danni Peng, et al.
Military Medicine|January 27, 2021
A Paradigm Shift in Critical Care Infrastructure in Complex Settings: Evaluating an Ultraportable Operating Room to Improve Field Surgical SafetyDebbie L Teodorescu, Stephen Okajima, Asad Moten, et al.
Science Signaling|January 10, 2013
Cycles of ubiquitination and deubiquitination critically regulate growth factor-mediated activation of Akt signalingWei-Lei Yang, Guoxiang Jin, Chien-Feng Li, et al.
Cell|August 6, 2013
Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progressionChia-Hsin Chan, John Kenneth Morrow, Chien-Feng Li, et al.
Blood|September 21, 2011
The role of Skp2 in hematopoietic stem cell quiescence, pool size, and self-renewalJing Wang, Fei Han, Juan Wu, et al.
Pageof 1